Accueil / Tag Archives: California

Tag Archives: California

Maverick Therapeutics to Unveil Pre-Clinical Data on Novel COBRATM Platform at American Association for Cancer Research 2019 Annual Meeting

Saturday, March 30th 2019 at 12:00pm UTC – Pre-clinical Data Characterize the Conditional and Potent Activity of the Company’s Novel COBRATM Platform, a Conditionally Active T-cell Engaging Therapeutic Designed to Target Solid Tumors – BRISBANE, Calif.–(BUSINESS WIRE)– Maverick Therapeutics Inc., a private biopharmaceutical company pioneering next-generation redirected T-cell targeted immunotherapies, …

Plus »

Gilead and Galapagos Announce Filgotinib Meets Primary and Key Secondary Endpoints in the Phase 3 FINCH 1 Rheumatoid Arthritis Study

Thursday, March 28th 2019 at 9:03pm UTC — Filgotinib 100 mg and 200 mg Doses Demonstrated Significantly Higher ACR20/50/70 Responses than Placebo in Patients with Prior Inadequate Methotrexate Response — — Significant Inhibition of Radiographic Progression Demonstrated with Both Doses of Filgotinib versus Placebo — — Safety Profile of Filgotinib …

Plus »

Gilead and Galapagos Report Updated Safety Information for Filgotinib in Rheumatoid Arthritis (RA)

Thursday, March 28th 2019 at 9:02pm UTC — Pooled Interim Phase 3 FINCH Program Data up to 24 Weeks and Phase 2b DARWIN 3 Long-Term Data Add to Evidence Supporting Filgotinib Safety Profile — FOSTER CITY, Calif. & MECHELEN, Belgium–(BUSINESS WIRE)– regulated information – Gilead Sciences, Inc. (NASDAQ: GILD) and Galapagos NV (Euronext …

Plus »

Gilead and Galapagos Announce Filgotinib Meets Primary Endpoint in the Phase 3 FINCH 3 Study in Methotrexate-Naïve Rheumatoid Arthritis Patients

Thursday, March 28th 2019 at 9:04pm UTC — Filgotinib 100 mg and 200 mg Plus Methotrexate (MTX) Demonstrated Significantly Higher ACR20/50/70 Responses Than Methotrexate Alone — — Filgotinib Safety Profile Consistent With Previously Reported Results — FOSTER CITY, Calif. and MECHELEN, Belgium–(BUSINESS WIRE)– regulated information – Gilead Sciences, Inc. (NASDAQ: GILD) …

Plus »

Cytonus Therapeutics Announces Poster Presentation at the 2019 American Association for Cancer Research Annual Meeting

Thursday, March 28th 2019 at 8:04pm UTC SAN DIEGO–(BUSINESS WIRE)– Cytonus Therapeutics Inc., a biotechnology company developing new platforms for delivering biologics, announced today that it will be presenting preclinical data for its Cargocyte™ technology platform at the American Association for Cancer Research (AACR) annual meeting March 29 – April …

Plus »

Veracyte Announces Participation in the 18th Annual Needham Healthcare Conference

Thursday, March 28th 2019 at 8:15pm UTC SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)– Veracyte, Inc. (Nasdaq: VCYT), a leading genomic diagnostics company, today announced that Bonnie H. Anderson, chairman and chief executive officer, is scheduled to present at the 18th Annual Needham Healthcare Conference in New York City on Wednesday, April 10, …

Plus »

NovaBay Pharmaceuticals Reports 2018 Fourth Quarter and Full Year Financial Results

Thursday, March 28th 2019 at 8:05pm UTC Conference call begins today at 4:30 p.m. Eastern time EMERYVILLE, Calif.–(BUSINESS WIRE)– NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova® for the domestic eye care market, reports financial results for the three and 12 months ended December …

Plus »

Agilent to Host National Academy of Engineering Business Meeting and Bioengineering Symposium

Thursday, March 28th 2019 at 3:00pm UTC Leading innovators will highlight their research in precision medicine and biological systems engineering SANTA CLARA, Calif.–(BUSINESS WIRE)– Agilent Technologies Inc. (NYSE: A) today announced that it will host the western regional conference of the National Academy of Engineering, along with a technical symposium—Bioengineering, …

Plus »

Abzena Expands Management Team: Appoints Campbell Bunce to the Role of Chief Scientific Officer and Bo Adair as Senior Vice President Process and Operations

Thursday, March 28th 2019 at 3:55pm UTC CAMBRIDGE, England & San Diego–(BUSINESS WIRE)– Abzena, the leading global biologics target to GMP partner research organisation, announced it has appointed Dr Campbell Bunce as Chief Scientific Officer (CSO) and Bo Adair MBA as Senior Vice President Process and Operations. This press release …

Plus »
>
Macbook Pro
* Intel Core i7 (3.8GHz, 6MB cache)
* Retina Display (2880 x 1880 px)
* NVIDIA GeForce GT 750M (Iris)
* 802.11ac Wi-Fi and Bluetooth 4.0
* Thunderbolt 2 (up to 20Gb/s)
* Faster All-Flash Storage (X1)
* Long Lasting Battery (9 hours)
BIENVENUE CHEZ BIOTECH FINANCES
Vous appréciez nos informations ?
Recevez nos alertes, nos dernières actualités, suivez-nous, enregistrez-vous gratuitement, rejoignez notre communauté. Merci à vous !
ARE YOU READY? GET IT NOW!
Increase more than 500% of Email Subscribers!
Your Information will never be shared with any third party.
DÉCOUVREZ LA SOLUTION STRATA !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHBzOi8vd3d3LmJpb3RlY2gtZmluYW5jZXMuY29tL3dwLWNvbnRlbnQvdXBsb2Fkcy8yMDE1LzA3L1NhdHJhLTIubXA0IiBmcmFtZWJvcmRlcj0iMCIgYWxsb3dmdWxsc2NyZWVuPjwvaWZyYW1lPg==
Retrouvez nous sur http://stratahealth.com/fr/
Un ensemble de solutions performantes
pour assurer le continuum de vos données.
Biotech Finances
SUIVEZ-NOUS, ENREGISTREZ-VOUS !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cueW91dHViZS5jb20vZW1iZWQvajhsU2NITzJtTTAiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
All rights reserved © Company Name, 2014
Concours Genopole Young Biotech Award
* 100 000 € pour la meilleure Biotech
* Réservé aux biotechs hors santé
* 6 mois d'hébergement gratuit
* Un accompagnement personnalisé
* Etude de marché offerte
* Expertise du projet par EY
* Et nombre d'autres avantages...
S'inscrire au 15H BIOTECH EXPRESS
Chaque jour à 15H recevez gratuitement les news des biotechs, des medtechs,et des fonds spécialisés. Levées ; partenariats ; nominations ; fusacq ; closing ; milestone...
2019 (C) All rights reserved.

En cochant cette case, j’accepte la Politique de confidentialité de ce site et de recevoir des informations de notre part.

S'inscrire au 15H BIOTECH EXPRESS
Chaque jour à 15H recevez gratuitement les news des biotechs, des medtechs,et des fonds spécialisés. Levées ; partenariats ; nominations ; fusacq ; closing ; milestone...
2019 (C) All rights reserved.

En cochant cette case, j’accepte la Politique de confidentialité de ce site et de recevoir des informations de notre part.